ablation for the management of atrial fibrillation (AF) has evolved as a
successful therapy widely used. Women with AF show a
higher risk for AF-related morbidity due to stroke, a poorer tolerance to
antiarrhythmic pharmacological therapy and a weaker quality of life; for this
reason a curative, catheter-based approach for AF appears very attractive in
women. Reported details on female AF population undergoing catheter ablation,
as well as success and complication rates will be reviewed.
Credits: Daniela Dugo; Stefano Bordignon; Laura Perrotta; Alexander Fürnkranz; KR Julian Chun; Boris Schmidt